Genmab A GMAB
NASDAQ GMAB
$54.07 -1.73 (-3.10%)
At close: Nov 10, 2026 · 4:00 PM EST

Genmab A (GMAB) Receivables (2023 - 2026)

Updated

Genmab A's Receivables was $1.28 billion in the quarter ended Jun 30, 2026, up 32.6% from the prior quarter.

Analysis

Genmab A (GMAB) Receivables (2023 - 2026) Analysis & Trends

As of Dec 31, 2025, Receivables at Genmab A came in at $1.2 billion, up 22.2% from the prior year.

  • In earlier years, Receivables was $979 million in the year ended Dec 31, 2024 (+24.6%) and $786 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 25.23 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 18.99 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 13.51 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 12.74 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 14.33 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 10.35 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 5.01 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 14.19 Bn
10 Genmab A 3.52 Bn -5.55 Bn 1.07 Bn 1.28 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.24 Bn
Jun 30, 2026 1.28 Bn
Mar 31, 2026 968.00 Mn
Dec 31, 2025 1.20 Bn
Jun 30, 2025 998.00 Mn
Dec 31, 2024 979.00 Mn
Dec 31, 2023 786.00 Mn
API Access

Genmab A Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=GMAB&period=max&api_key=YOUR_API_KEY